JPMORGAN CHASE & CO - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 3 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$02580.0%0.00%
Q4 2021$0
-100.0%
258
-96.4%
0.00%
Q3 2021$8,000
-97.3%
7,170
-96.3%
0.00%
Q2 2021$296,000
-30.0%
191,523
+8.7%
0.00%
Q1 2021$423,000
-22.0%
176,221
-4.2%
0.00%
Q4 2020$542,000
+622.7%
183,922
+281.1%
0.00%
Q3 2020$75,000
-35.9%
48,256
+2.3%
0.00%
Q2 2020$117,000
+42.7%
47,171
+17.6%
0.00%
Q1 2020$82,000
-12.8%
40,125
+31.5%
0.00%
Q4 2019$94,000
+70.9%
30,524
+84.5%
0.00%
Q3 2019$55,000
+27.9%
16,541
+19.3%
0.00%
Q2 2019$43,000
+22.9%
13,860
+13.8%
0.00%
Q1 2019$35,000
-31.4%
12,184
-4.5%
0.00%
Q4 2018$51,000
-5.6%
12,755
+10.3%
0.00%
Q3 2018$54,000
-34.9%
11,567
+14.1%
0.00%
Q2 2018$83,00010,142
+112588.9%
0.00%
Q1 2018$090.0%0.00%
Q4 2017$090.0%0.00%
Q3 2017$090.0%0.00%
Q2 2017$090.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders